Cartagenia Raises $2.9M in Private Financing | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cartagenia, a Leuven, Belgium-based firm developing software and database systems for genetic analyses, today said that it has received a capital injection of €2.2 million ($2.9 million).

The company said that it would use the funds to further develop its market presence, open an office in the US, and invest in a new product line.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.